Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2018;7(3): 148-151. doi:
10.15171/jrip.2018.37
Original
Renal function in β-thalassemia major receiving desferal versus deferasirox
Foroogh Sabzghabaei
1
, Maryam Darnahal
1
* , Azita Azarkeivan
Cited by CrossRef: 2
1- Moosazadeh M, Gorji N, Nasiri P, Shafaroudi A. Comparison of decayed, missing, filled teeth index between thalassemia major patients and control group in Iran: a systematic review and meta-analysis.
BDJ Open
. 2020;6(1)
[Crossref]
2- Najat D, Karim L. USING CYSTATIN C TO ASSESS KIDNEY DAMAGE IN BETA THALASSEMIC PATIENTS RESIDING IN SULAIMANI CITY.
JSMC
. 2021;11(1):55
[Crossref]
3- Falahati V, Ghasemi A, Safari M, Ghaffari K, Yousefichaijan P, Zamanian M. Renal function in patients with thalassemia major receiving Exjade® dispersible tablets and a new film-coated tablet formulation of deferasirox (Nanojade®).
Adv Biomed Res
. 2022;11(1):84
[Crossref]